In this article we will explore all aspects related to 1-Aminomethyl-5-methoxyindane, from its origin to its impact on today's society. We will analyze how 1-Aminomethyl-5-methoxyindane has influenced different areas, from culture to economics, including politics and technology. Additionally, we will examine the role of 1-Aminomethyl-5-methoxyindane in people's daily lives and how it has evolved over time. Through this comprehensive analysis, we aim to offer a complete and in-depth view of 1-Aminomethyl-5-methoxyindane, with the aim of providing a comprehensive understanding of its importance and relevance today.
![]() | |
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C11H15NO |
Molar mass | 177.247 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
1-Aminomethyl-5-methoxyindane (AMMI), is a drug developed by a team led by David E. Nichols at Purdue University, which acts as a selective serotonin releasing agent (SSRA) and binds to the serotonin transporter with similar affinity to DFMDA.[1][2]